<DOC>
	<DOC>NCT01557010</DOC>
	<brief_summary>The purpose of this study is to evaluate efficacy, safety of administered DWP05195 in Postherpetic Neuralgia.</brief_summary>
	<brief_title>Evaluate the Efficacy and Safety of DWP05195 in Subjects With Post-Herpetic Neuralgia</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Neuralgia, Postherpetic</mesh_term>
	<criteria>Male or Female subjects aged 20 to 80 years Subjects with symptoms of neuropathic pain associated with postherpetic neuralgia(PHN). Subjects must have pain present for &gt; 3 months after healing of the acute herpes zoster skin rash. Other severe pain that may potentially confound pain assessment. Subjects with symptoms of neuropathic pain applied Medical Equipment Within 2 years: Subjects were diagnosed with cancer</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>